EGFR and cholangiocarcinoma: Feng et al. [96] reported a patient with unresectable/metastatic CCA who was resistant to chemotherapy and radiotherapy and was successively treated with CAR-T cells targeting epidermal growth factor receptor (EGFR) and CD133, respectively.